InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
sjk2108 Free
08/12/22 12:35 PM
profile icon
fantomphan Free
08/12/22 11:51 AM
profile icon
sjk2108 Free
08/10/22 5:58 PM
profile icon
andy55q Free
08/10/22 7:36 AM
profile icon
fantomphan Free
08/09/22 5:29 PM
profile icon
eskay1954 Free
08/09/22 2:20 PM
profile icon
eskay1954 Free
08/09/22 2:16 PM
profile icon
fantomphan Free
08/08/22 8:51 PM
profile icon
andy55q Free
08/05/22 7:28 AM
profile icon
andy55q Free
08/03/22 7:13 AM
profile icon
Paulness Free
08/02/22 8:24 PM
profile icon
Good Sport Free
08/02/22 4:17 PM
profile icon
andy55q Free
08/02/22 7:54 AM
profile icon
Good Sport Free
07/30/22 2:25 PM
profile icon
andy55q Free
07/28/22 8:18 AM
profile icon
Good Sport Free
07/27/22 9:03 AM
profile icon
andy55q Free
07/27/22 8:12 AM
profile icon
Paulness Free
07/25/22 8:13 AM
profile icon
andy55q Free
07/20/22 7:05 AM
profile icon
andy55q Free
07/14/22 6:51 AM
profile icon
andy55q Free
07/13/22 7:44 AM
profile icon
andy55q Free
07/13/22 7:42 AM
profile icon
Paulness Free
07/08/22 9:18 AM
profile icon
fantomphan Free
07/08/22 9:13 AM
profile icon
andy55q Free
07/08/22 6:24 AM
profile icon
Paulness Free
07/01/22 8:15 AM
profile icon
fantomphan Free
07/01/22 7:51 AM
profile icon
andy55q Free
06/30/22 7:38 AM
profile icon
andy55q Free
06/29/22 7:46 AM
profile icon
raptorjockey Free
06/24/22 5:20 PM
profile icon
andy55q Free
06/22/22 8:31 AM
profile icon
andy55q Free
06/17/22 5:47 PM
profile icon
andy55q Free
06/15/22 8:10 AM
profile icon
andy55q Free
06/08/22 7:09 AM
profile icon
andy55q Free
06/05/22 7:29 AM
profile icon
eskay1954 Free
06/02/22 11:00 AM
profile icon
Paulness Free
06/02/22 8:13 AM
profile icon
Paulness Free
06/01/22 9:19 AM
profile icon
andy55q Free
06/01/22 7:40 AM
profile icon
andy55q Free
05/27/22 8:14 AM
profile icon
andy55q Free
05/25/22 6:44 AM
profile icon
Paulness Free
05/19/22 9:02 AM
profile icon
andy55q Free
05/18/22 7:36 AM
profile icon
biotech48 Free
05/12/22 3:07 PM
profile icon
ssmmss Free
05/12/22 9:25 AM
profile icon
andy55q Free
05/12/22 6:58 AM
profile icon
andy55q Free
05/11/22 6:22 AM
profile icon
eskay1954 Free
05/06/22 3:50 PM
profile icon
andy55q Free
05/06/22 8:35 AM

CytoSorbents Corporation (CTSO) RSS Feed

Followers
241
Posters
593
Posts (Today)
0
Posts (Total)
27409
Created
10/18/08
Type
Free
Moderators
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 68 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents recently initiated its pivotal REFRESH (REduction in FREe Hemoglobin) 2 trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 46,000 human treatments to date. 

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $22 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at http://www.cytosorbents.com and http://www.cytosorb.com or follow us on Facebook and Twitter.

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post